Add BrightSurf on Google Email

Search results for “Microbiology”

1,000+ results for "Microbiology"

Antibiotics do not reduce risk of dying in adults hospitalised with common respiratory infections, suggests study

A new study published at ECCMID 2023 found that antibiotics do not reduce the risk of dying in adults hospitalised with common viral respiratory infections like influenza. The research suggests a restrictive antibiotic strategy for these types of infections may be warranted to reduce unnecessary prescribing and combat antimicrobial res...

Multi-drug resistant organisms can be transmitted between healthy dogs and cats and their hospitalised owners

A study of over 2,800 hospital patients and their companion animals found that sharing multidrug-resistant organisms (MDROs) between pets and owners is possible. However, the rate of MDRO transmission from pets to humans was very low, suggesting that neither cat nor dog ownership is a major risk factor for hospital-acquired infections.

PCR panels reduce costs, hospitalizations and antibiotic use for acute GI infections

A new study published in Journal of Clinical Microbiology shows that using multiple PCR panels can identify more pathogens, notably diarrhea-causing E. coli and enteric viruses, and do so more rapidly than a conventional workup. This results in lower healthcare costs, reduced hospitalizations, and decreased antibiotic use.

SourceAmerican Society for Microbiology·JournalJournal of Clinical Microbiology·DateMar 15, 2023

Not enough new antibiotics in the pipeline, concludes WHO review – especially those targeting deadly drug-resistant microbes

A recent WHO review reveals a significant shortage of new antibiotics in the pipeline, with only 12 approved drugs introduced between 2017 and 2021. The majority of these drugs target non-critical pathogens, leaving critical ones like Acinetobacter baumannii and Pseudomonas aeruginosa underrepresented.

Long Covid is much less likely after omicron than after variant circulating at start of COVID-19 pandemic

A new study published at the European Congress of Clinical Microbiology & Infectious Diseases found that healthcare workers infected with the original SARS-CoV-2 virus were more likely to experience long Covid symptoms than those who had the omicron variant. The research suggests that omicron may be less likely to lead to long Covid, p...

Study shows those infected with COVID in the first wave in 2020 were 40% less likely than those who were not to get COVID-19 during the first six months of Omicron activity

A Canadian study found that those infected with COVID-19 in the first wave in 2020 were 40% less likely to get infected during the first six months of Omicron activity. Older adults, particularly those aged 65 and above, were significantly less likely to be infected than younger adults.

Turning a poison into food

Researchers at the Max Planck Institute for Marine Microbiology reveal how a specific enzyme, Fsr, converts sulfite into sulfide, allowing methanogens to grow safely on toxic substances. This discovery opens opportunities for biotechnological applications and provides insights into the evolution of these microorganisms.

SourceMax Planck Institute for Marine Microbiology·JournalNature Chemical Biology·DateJan 19, 2023

Slime for the climate, delivered by brown algae

Researchers discovered that brown algae's fucoidan can remove large amounts of carbon dioxide from the global cycle in the long term. The fucoidan is a recalcitrant molecule that does not return to the atmosphere quickly, making the brown algae particularly effective in removing carbon dioxide from the atmosphere.

SourceMax Planck Institute for Marine Microbiology·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 26, 2022

Oil-based systems show promise for eradicating salmonella on food production machinery

A new study published in Applied and Environmental Microbiology suggests that oil formulations with food-grade organic acids can kill dried Salmonella on stainless steel surfaces. This approach has the potential to replace water-based cleaning methods, which promote microbial growth and are often challenging to use.

SourceAmerican Society for Microbiology·JournalApplied and Environmental Microbiology·TypeExperimental study·DateAug 8, 2022

Longest known COVID-19 infection – 505 days – described by UK researchers

Researchers from King's College London and Guy's and St Thomas' NHS Foundation Trust studied nine immunocompromised patients with persistent COVID-19 infections, finding that five developed at least one mutation seen in variants of concern. The study provides evidence that new variants may develop in immunocompromised individuals.

People at risk of future heart disease and stroke may be at greater risk for severe COVID-19

A study of nearly a million adults in England found that those at risk of heart attack or stroke over the next 10 years are substantially more likely to become seriously unwell with COVID-19. People with elevated cardiovascular risk were six times as likely to die from COVID-19 and had three times the risk of hospitalization, according...

Both antibiotic resistant bacteria and genes transmitted between healthy dogs and cats and their owners, finds study in UK and Portugal

Researchers found that healthy companion animals and their owners can transmit antibiotic-resistant bacteria and genes to each other, highlighting the importance of hygiene practices around pets. The study suggests that even low-level shedding of bacteria by healthy carriers can pose a risk to vulnerable individuals.

New analysis of investigational COVID antiviral drug molnupiravir shows it appears to clear virus equally well in immunocompromised patients and those who are immunocompetent

A new analysis of data on molnupiravir shows the drug effectively clears active SARS-CoV-2 virus in both immunocompromised and non-immunocompromised patients. The study found similar reductions in viral replication and no infectious virus detected after treatment, indicating equal efficacy in both groups.

New virology data shows the investigational COVID antiviral drug molnupiravir eliminates actively infectious SARS-CoV-2 virus by day 3 of starting therapy

New data from the MOVe-OUT trial reveals that molnupiravir significantly reduces SARS-CoV-2 infection within three days of treatment. In contrast, those receiving a placebo took up to five days to clear the virus. The study confirms molnupiravir's effectiveness in accelerating viral RNA decline and eliminating infectious virus.

Evidence continues to build that organ donation from people dying after a positive COVID-19 test is safe and does not transmit SARS-CoV-2 to the recipient

The European Society of Clinical Microbiology and Infectious Diseases finds organ donation from COVID-19 patients is safe and does not transmit SARS-CoV-2. Recipients with asymptomatic infections are also now eligible for transplant, but must be triple-vaccinated.

Early study shows that organ donation from dying patients that have tested positive for COVID-19 is safe and does not infect recipients with SARS-CoV-2

Organ donation from dying COVID-19 patients appears to be safe and does not infect recipients with SARS-CoV-2. The study found all 6 abdominal organs had stable graft function and no unexpected rejection occurred.

SourceEuropean Society of Clinical Microbiology and Infectious Diseases·JournalClinical Microbiology and Infection·DateMar 22, 2022

Evidence is currently insufficient to show omicron variant has a shorter period of infectiousness compared with previous variants

The omicron variant's infectiousness period is uncertain, with evidence suggesting it may not be shorter than previous variants. Dr Marjolein Irwin-Knoester recommends a maximum of 7-day isolation for most cases, striking a balance between virus infectivity and community acceptance.